{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T20:36:12Z","timestamp":1778099772253,"version":"3.51.4"},"reference-count":0,"publisher":"Esmon Publicidad, SA","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Investig Allergol Clin Immunol"],"published-print":{"date-parts":[[2025,6,18]]},"abstract":"<jats:p>Eosinophilic esophagitis (EoE) is a chronic allergic condition affecting the esophagus and driven by food antigens. Many individuals diagnosed with EoE have other allergic conditions, such as food allergy, asthma, allergic rhinitis, and atopic dermatitis. The clinical goals of therapy in EoE include symptomatic, histologic, and endoscopic remission. The current paradigm for the treatment of EoE in Spain includes proton pump inhibitors, swallowed topical corticosteroids, and food elimination diets. These treatments have proven very effective in clinical studies. In April 2024, the Spanish Agency for Medicines and Medical Products approved dupilumab as the second drug for the treatment of EoE, thus adding this biologic to the therapeutic arsenal in EoE.\nThe present review includes a positioning statement by the authors, all of whom are members of the Spanish Society of Allergy and Clinical Immunology Food-EoE Working Group<\/jats:p>","DOI":"10.18176\/jiaci.1038","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T11:46:41Z","timestamp":1734608801000},"page":"170-178","source":"Crossref","is-referenced-by-count":3,"title":["Position Paper on the Treatment of Eosinophilic Esophagitis With Dupilumab"],"prefix":"10.18176","volume":"35","author":[{"given":"M","family":"Tom\u00e1s-P\u00e9rez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Domenech-Witek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MR","family":"\u00c1vila-Castellano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Carballas-V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AA","family":"V\u00e1squez-Bautista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Jover-Cerd\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Gonz\u00e1lez-Mendiola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7491","published-online":{"date-parts":[[2025,6,19]]},"container-title":["Journal of Investigational Allergology and Clinical Immunology"],"original-title":["English"],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T09:49:07Z","timestamp":1750326547000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jiaci.org\/summary\/vol35-issue3-num3068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,18]]},"references-count":0,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,6,19]]},"published-print":{"date-parts":[[2025,6,18]]}},"URL":"https:\/\/doi.org\/10.18176\/jiaci.1038","relation":{},"ISSN":["1018-9068"],"issn-type":[{"value":"1018-9068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,18]]}}}